Impact of age on outcome of CAR-T cell therapies for large B-cell lymphoma: the GLA/DRST experience

被引：26

作者：

Dreger, Peter ^{[1
]}

Holtick, Udo ^{[2
,3
]}

Subklewe, Marion ^{[4
]}

von Tresckow, Bastian ^{[5
]}

Ayuk, Francis ^{[6
]}

Wagner, Eva ^{[7
]}

Wulf, Gerald ^{[8
]}

Marks, Reinhardt ^{[9
]}

Penack, Olaf ^{[10
]}

Schnetzke, Ulf ^{[11
]}

Koenecke, Christian ^{[12
]}

von Bonin, Malte ^{[13
]}

Stelljes, Matthias ^{[14
]}

Glass, Bertram ^{[15
]}

Baldus, Claudia D. ^{[16
]}

Vucinic, Vladan ^{[17
]}

Mougiakakos, Dimitrios ^{[18
,19
]}

Topp, Max ^{[20
]}

Schroers, Roland ^{[21
]}

Wolff, Daniel ^{[22
]}

Thomas, Simone ^{[22
,23
]}

Kroeger, Nicolaus ^{[6
]}

Bethge, Wolfgang A. ^{[24
]}

机构：

[1] Univ Hosp Heidelberg, Dept Hematol & Oncol, Heidelberg, Germany

[2] Univ Cologne, Med Fac, Dept Internal Med 1, Cologne, Germany

[3] Univ Cologne, Univ Hosp Cologne, Cologne, Germany

[4] Ludwig Maximilians Univ Munchen, Univ Hosp Munich, Dept Hematol & Oncol, Munich, Germany

[5] Univ Duisburg Essen, Univ Hosp Essen, West German Canc Ctr, Dept Hematol & Stem Cell Transplantat, Essen, Germany

[6] Univ Hosp Hamburg, Dept Stem Cell Transplantat, Hamburg, Germany

[7] Univ Hosp Mainz, Dept Hematol & Oncol, Mainz, Germany

[8] Univ Med Goettingen, Clin Hematol & Med Oncol, Gottingen, Germany

[9] Univ Hosp Freiburg, Dept Hematol & Oncol, Freiburg, Germany

[10] Univ Hosp Charite, Dept Hematol & Oncol, Berlin, Germany

[11] Univ Hosp Jena, Dept Hematol & Oncol, Jena, Germany

[12] Univ Hosp Hannover, Dept Hematol & Oncol, Hannover, Germany

[13] Univ Hosp Dresden, Dept Hematol & Oncol, Dresden, Germany

[14] Univ Hosp Muenster, Dept Hematol & Oncol, Muenste, Germany

[15] Klinikum Berlin, Dept Hematol & Oncol, Berlin, Germany

[16] Univ Hosp Kiel, Dept Hematol & Oncol, Kiel, Germany

[17] Univ Hosp Leipzig, Leipzig, Germany

[18] Univ Hosp Erlangen, Dept Hematol & Oncol, Erlangen, Germany

[19] Univ Hosp Magdeburg, Dept Hematol, Magdeburg, Germany

[20] Univ Hosp Wurzburg, Dept Hematol & Oncol, Wurzburg, Germany

[21] Univ Hosp Bochum, Dept Hematol & Oncol, Bochum, Germany

[22] Univ Hosp Regensburg, Dept Internal Med 3, Hematol & Oncol, Regensburg, Germany

[23] Leibniz Inst Immunotherapy, Regensburg, Germany

[24] Univ Hosp Tuebingen, Dept Hematol & Oncol, Tubingen, Germany

来源：

BONE MARROW TRANSPLANTATION | 2023年 / 58卷 / 02期

关键词：

D O I：

10.1038/s41409-022-01867-4

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

引用

页码：229 / 232

页数：4

共 50 条

[21] The intrinsic defects of T cells impact the efficacy of CAR-T therapy in patients with diffuse large B-cell lymphoma
Jinrong Zhao
Chong Wei
Shuqing Wang
Yan Zhang
Wei Wang
Danqing Zhao
Zi Wang
Zhipeng Zhou
Jing Bai
Wei Zhang
Daobin Zhou
Blood Cancer Journal, 13
[22] The intrinsic defects of T cells impact the efficacy of CAR-T therapy in patients with diffuse large B-cell lymphoma
Zhao, Jinrong
Wei, Chong
Wang, Shuqing
Zhang, Yan
Wang, Wei
Zhao, Danqing
Wang, Zi
Zhou, Zhipeng
Bai, Jing
Zhang, Wei
Zhou, Daobin
BLOOD CANCER JOURNAL, 2023, 13 (01)
[23] Retrospective Comparison of Survival Projections for CAR T-Cell Therapies in Large B-Cell Lymphoma
Elisabeth F. P. Peterse
Elisabeth J. M. Verburg-Baltussen
Alexa Stewart
Fei Fei Liu
Christopher Parker
Maarten Treur
Bill Malcolm
Sven L. Klijn
PharmacoEconomics - Open, 2023, 7 : 941 - 950
[24] Retrospective Comparison of Survival Projections for CAR T-Cell Therapies in Large B-Cell Lymphoma
Peterse, Elisabeth F. P.
Verburg-Baltussen, Elisabeth J. M.
Stewart, Alexa
Liu, Fei Fei
Parker, Christopher
Treur, Maarten
Malcolm, Bill
Klijn, Sven L.
PHARMACOECONOMICS-OPEN, 2023, 7 (6) : 941 - 950
[25] Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Mantle Cell Lymphoma: Is It Time to Consider CAR-T for All
Zelenetz, Andrew D.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2020, 18 (12): : 1764 - 1766
[26] The Role of the Tumor Microenvironment in T-Cell Redirecting Therapies of Large B-Cell Lymphoma: Lessons Learned from CAR-T to Bispecific Antibodies
Lepik, Kirill V.
Markelov, Vladislav V.
CANCERS, 2025, 17 (02)
[27] CAR-T for large B-cell lymphomas: the clock is ticking
Chong, Elise A.
BLOOD ADVANCES, 2024, 8 (11) : 2980 - 2981
[28] CAR T-Cell Therapy in Large B-Cell Lymphoma
Quintas-Cardama, Alfonso
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (11): : 1065 - 1065
[29] Novel CAR T cell therapies for patients with large B cell lymphoma
Goto, Hideki
Onozawa, Masahiro
Teshima, Takanori
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2024, 120 (01) : 6 - 14
[30] Outcome of Patients with Diffuse Large B-Cell Lymphoma Relapsing after Autologous Transplant before Availability of CAR-T Cell Treatment
von Matt, Stefanie
Bacher, Ulrike
Banz, Yara
Taleghani, Behrouz Mansouri
Novak, Urban
Pabst, Thomas
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2023, 15 (01)

← 1 2 3 4 5 →